Google.org is a philanthropic arm of Google, a multinational technology company. It funds and supports nonprofits globally, providing them with funding, tools, and volunteers. Google.org has committed approximately $100 million annually to these efforts, aiming to extend the reach of innovative nonprofits and create lasting global impact.
VP and GM, Google Cloud Platform and Technical Infrastructure
Sumiran Das
Growth Equity Investor at Google Capital
Jacquelline Fuller
President
Raj Gajwani
Director, Orion Wifi @ Google Area 120
Carletta Higginson
Director, Global Head of Music Publishing
Rahul Jain
Lead, Venture Capital and Startups - Google Cloud
Aftab Jutt
CEO
Sushrut Karanjkar
Director
David Krane
Mnaging Partner
Jess Kuizon
CEO
Bibiana Leite
Director, Scaled Partnerships
Anthony Nakache
Managing Director, Google MENA
David Reshef
Venture Partner
Issi Rozen
Venture Partner
Philipp Schindler
Senior Vice President and Chief Business Officer
Aparna Sinha
Director, Product Management for Kubernetes and Anthos
Andrew R. Whalley
Director, Chrome Security
Andy Wheeler
General Partner
LightRoom Premium Mod APK Download Android
CEO
Co khi Nhan Do
CEO
Past deals in North America
Overture Life
Venture Round in 2025
Overture Life, Inc. is a biotechnology company established in 2017 and headquartered in New York, New York. The company specializes in developing robotic technology and medical devices aimed at automating the in vitro fertilization (IVF) process. Overture Life's innovations include novel embryo testing methodologies and automated cryopreservation services, which help fertility clinics identify viable embryos prior to implantation. By streamlining the IVF process, Overture Life aims to make artificial insemination more accessible, reduce costs, optimize resource use, and improve success rates for practitioners and patients alike.
Wiz
Acquisition in 2025
Wiz, Inc. is a cybersecurity company founded in 2020, with headquarters in Palo Alto, California, and an additional office in Tel Aviv, Israel. The company specializes in cloud security, providing enterprises with a platform that enables them to identify security issues within their public cloud infrastructure. Wiz's innovative solution offers a comprehensive, cloud-native visibility tool that analyzes the entire cloud environment, delivering a 360-degree view of security risks across various platforms, including clouds, containers, and workloads. The platform utilizes actionable, graph-based analysis to facilitate in-depth risk assessment and root cause analysis without the need for agents, allowing organizations to enhance their security posture effectively.
Omni
Series B in 2025
Omni is a multifaceted company based in San Francisco, California, that specializes in business intelligence, cybersecurity, and cloud engineering services. Its primary offering is a unique business intelligence platform that merges the reliability of a shared data model with the flexibility of SQL, allowing users to easily access, explore, and share curated data metrics. This platform is designed to streamline the data analytics process, enabling clients to focus on deriving meaningful insights without the complications often associated with data management. Additionally, Omni operates a rentals platform that connects local businesses with community members, providing access to a variety of rental items such as bikes, surfboards, and camping equipment. This initiative enhances community engagement by making diverse products readily available for short-term use.
Harvey
Series D in 2025
Harvey is an artificial intelligence technology service provider for knowledge workers. It uses AI to answer legal questions and lands cash from OpenAI. The product provides lawyers with a natural language interface for their existing legal workflow. It offers a unified and intuitive interface for all legal workflows, allowing lawyers to describe tasks in plain English instead of using a suite of complex and specialized tools for niche tasks. Harvey was founded in 2022 and is based in Washington, DC.
Clear Labs
Series D in 2025
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.
North Carolina Central University
Grant in 2024
North Carolina Central University (NCCU), established in 1910, is a historically black college located in Durham, North Carolina. It has built a strong reputation for its commitment to academic excellence, research, and cultural awareness. NCCU offers over 100 programs across nearly 30 academic departments, providing both undergraduate and graduate degrees. Notable offerings include unique programs such as a master’s degree in Jazz Studies and a bachelor’s degree in Apparel Design, alongside joint graduate programs in law and business. The university actively promotes diversity, welcoming students of all races and ethnicities, and provides various financial aid options, including institutional scholarships and need-based government programs. With a focus on preparing students for success in a global marketplace, NCCU continues to play a vital role in higher education and community development.
Intersect Power
Private Equity Round in 2024
Intersect Power is a clean infrastructure company focused on developing innovative and scalable low-carbon solutions for energy and commodity markets. The company specializes in all phases of project development, including design, engineering, finance, and operations. Intersect Power has a robust pipeline of 3.2 GWDC of late-stage solar and storage projects expected to commence operations by 2023, along with a growing portfolio of other clean infrastructure assets. Additionally, the company has successfully developed and sold over 1.7 GWDC of contracted solar projects in California and Texas, which are now managed by third-party investors. Intersect Power also explores advanced technologies such as green hydrogen and carbon capture, providing sustainable alternatives to fossil fuels for various applications, including transportation and chemical processes.
Cala Health
Series C in 2024
Cala Health, Inc. is a bioelectronic medicine company based in Burlingame, California, founded in 2013. It specializes in developing wearable neuromodulation therapies aimed at treating chronic diseases. The company's flagship product, Cala Trio, is a non-invasive prescription therapy designed to provide transient relief from hand tremors in adults with essential tremor. By integrating advancements in neuroscience and technology, Cala Health focuses on delivering individualized peripheral nerve stimulation. In addition to its work on essential tremor, the company is also developing therapies for other neurological conditions, including Parkinson's disease, as well as applications in psychiatry, cardiology, and autoimmune disorders.
Synapticure
Series A in 2024
Synapticure is a virtual clinical care platform dedicated to supporting patients with neurodegenerative diseases, including dementia, Parkinson's, and ALS, throughout the United States. Founded by patients, the company offers comprehensive care services that include access to disease-specific neurologists, speech and language therapy, and 24/7 care coordination. Utilizing advances in science, technology, and computational analytics, Synapticure ensures that patients receive tailored treatment and support in their own homes. The platform integrates medical, dental, vision, and life insurance plans to facilitate easy access to a range of healthcare services, including behavioral health support such as psychiatry and therapy, all aimed at enhancing the quality of life for individuals facing these challenging conditions.
2Gether-International
Grant in 2024
2Gether-International is a civic and social organization established in 2015, based in Washington, District of Columbia. The organization is dedicated to assisting startups led by individuals with disabilities, providing essential resources to foster their growth and success. By connecting disabled founders with investors and facilitating fundraising efforts, 2Gether-International aims to create an inclusive entrepreneurial ecosystem. Through its accelerator program, the organization empowers these entrepreneurs to develop thriving businesses, enhancing opportunities and support for underrepresented groups in the startup community.
Partnership for Public Service
Grant in 2024
The Partnership for Public Service is a nonpartisan organization based in Washington, DC, dedicated to enhancing the effectiveness of government for the American public. It focuses on improving the federal workforce and promoting good governance through various initiatives and research. By fostering collaboration between the public and private sectors, the organization aims to address challenges within government and advocate for reforms that support a more efficient and responsive administration. Its efforts are designed to strengthen public service and ensure that government institutions meet the needs of citizens effectively.
Rippl Care
Series A in 2024
Rippl Care is a mental health company based in Seattle, Washington, dedicated to supporting seniors experiencing dementia and other neurocognitive disorders. Founded in 2021, the company employs a value-based approach and innovative technology to deliver comprehensive care tailored to individual needs. By prioritizing the empowerment of its clinicians, Rippl Care adopts a novel care model that enables seniors to receive personalized support through various channels, including phone, online, and in-home visits. This commitment to enhancing the quality of care for those affected by neurocognitive conditions sets Rippl Care apart in the mental health landscape.
Dandelion Energy
Series C in 2024
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.
UJET
Series D in 2024
UJET, Inc. specializes in developing customer support software and platform solutions that enhance customer communications. Founded in 2015 and headquartered in San Francisco, with additional offices in New York and Seoul, the company offers a cloud contact center platform that integrates seamlessly with major customer relationship management systems like Salesforce, Zendesk, and Kustomer. UJET's platform is designed for the smartphone era, modernizing digital and in-app customer experiences while eliminating the need for customers to switch between different communication channels. By utilizing multiple voices, online messaging, and mobile features, UJET assists customer service agents in managing incoming calls and resolving issues efficiently. The incorporation of artificial intelligence across its services further automates processes and improves interaction quality. Additionally, UJET provides a wait time messaging tool that offers live updates to customers while they are on hold, enhancing overall service satisfaction.
Cribl
Series E in 2024
Cribl, Inc. is a software company specializing in data management solutions that help organizations efficiently handle log ingestion and analytics at scale. Founded in 2017 and based in San Francisco, California, Cribl offers Logstream, a platform that enables users to transform and route logs and metrics in real-time while minimizing wasted data processing. Its software provides capabilities for implementing observability pipelines capable of managing data at Petabyte scale, allowing businesses to prioritize high-value information and ensure compliance with privacy regulations. Cribl empowers tech professionals with the flexibility to manage their data without compromising on performance or control, thereby enhancing operational intelligence and decision-making processes.
Mechanical Orchard
Series B in 2024
Mechanical Orchard is a technology company based in San Francisco that specializes in modernizing and maintaining essential business applications for large enterprises. By leveraging GenAI and advanced software engineering practices, the company focuses on updating legacy computer systems, thereby reducing risks associated with modernization. Mechanical Orchard provides cloud operations as a service, ensuring that businesses can run secure, reliable, and scalable applications. Its mission is to empower clients to remain competitive in a rapidly evolving marketplace, helping them to adapt and thrive amid technological change.
Harvey
Series C in 2024
Harvey is an artificial intelligence technology service provider for knowledge workers. It uses AI to answer legal questions and lands cash from OpenAI. The product provides lawyers with a natural language interface for their existing legal workflow. It offers a unified and intuitive interface for all legal workflows, allowing lawyers to describe tasks in plain English instead of using a suite of complex and specialized tools for niche tasks. Harvey was founded in 2022 and is based in Washington, DC.
Cardurion Pharmaceuticals
Series B in 2024
Cardurion Pharmaceuticals, LLC is a biotechnology company based in Boston, Massachusetts, established in 2017. The company specializes in developing innovative therapeutics aimed at treating heart failure and other cardiovascular diseases. Cardurion is advancing clinical programs that focus on inhibiting PDE9 and CaMKII, utilizing its knowledge of cardiovascular signaling pathways to meet significant patient needs in this area.
LevelTen Energy
Series D in 2024
LevelTen Energy, Inc. is a Seattle-based company founded in 2016 that operates a renewable energy transaction marketplace. This platform serves to connect corporate and industrial power buyers with power purchase agreements (PPAs) from utility-scale wind, solar, and storage projects. By facilitating access to a wide range of renewable energy options, LevelTen Energy enables clients to secure fixed-price renewable energy solutions and benefit economically from large-scale projects. The company's technology-driven marketplace enhances the efficiency of transactions, allowing buyers, advisors, and sellers to achieve better deals in a streamlined manner. Through its services, LevelTen Energy plays a significant role in advancing the adoption of renewable energy in the corporate sector.
Hebbia
Series B in 2024
Hebbia Inc. is a technology company that specializes in developing AI productivity tools tailored for knowledge workers. Established in 2020 and headquartered in West Hollywood, California, Hebbia offers a unique platform designed to facilitate complex task management by transforming prompts into actionable processes completed by AI agents. The platform is utilized by professionals in finance, law, government, and pharmaceuticals, enabling them to handle extensive workflows involving millions of documents. Unlike many AI systems that operate as a black box, Hebbia's technology is transparent, allowing users to verify and collaborate effectively with the AI. It efficiently ingests both structured and unstructured data from various sources, retrieves relevant information upon request, and presents answers in a user-friendly, spreadsheet-like format, thereby supporting comprehensive workflow automation.
Solstice
Grant in 2024
Solstice is a company dedicated to making renewable energy accessible to all Americans through community-shared solar power. Founded in 2016 and headquartered in Cambridge, Massachusetts, Solstice provides comprehensive customer solutions for shared solar, including subscriber aggregation and management services aimed at solar developers, utilities, and other providers. By employing community organizing techniques along with its innovative online marketplace, Solstice aggregates consumer demand to facilitate the deployment of community solar projects. This approach enables renters and homeowners with non-optimal roofs to participate in solar energy, allowing them to save on utility bills without upfront costs. Solstice is driven by a commitment to energy equity, striving to ensure that affordable renewable energy is available to every household, regardless of income or credit status. The company has been recognized with multiple awards for its contributions to clean energy and entrepreneurship.
Dakota State University
Grant in 2024
DSU was founded in 1881 as a school for teacher education in the Dakota Territory. Today, they're one of the most technologically-advanced campuses in the Midwest. A public university, they're are governed by the South Dakota System Board of Regents and accredited by the Higher Learning Commission. They specialize in computer management, computer information systems, and other related undergraduate and graduate programs. They stay true to their roots by placing special emphasis on the preparation of teachers with expertise in the use of computer technology in the teaching and learning process. They have more than 35 majors to choose from, plus a robust graduate program.
Northeastern State University
Grant in 2024
For a bachelor’s or graduate degree, continuing education, or study abroad program in the Tahlequah, Oklahoma area, look to Northeastern State University. Programs available for study include subjects such as Business Administration, Computer Science, Criminal Justice, Environmental Health and Safety Management, Health and Physical Education, Hospitality and Tourism Management, Psychology, Supply Chain Management, and Visual Communication. The financial aid counselors of NSU can help you apply for loans, the federal Pell Grant, Supplemental Educational Opportunity Grant, Oklahoma Tuition Aid Grant, Smart Grant, Academic Competitiveness Grant, and many scholarships based on need, merit, academics, and athletics. With their help, you may qualify for funds to pay for educational expenses like tuition and books. When it comes time to look for employment, NSU’s career services can help you achieve your career goals. Among the career services are counselors, career events, interviews, info sessions, workshops, job resources, employment data, and job, internship, and graduate school fairs.
University of Arizona
Grant in 2024
The University of Arizona, founded in 1885 and located in Tucson, Arizona, is a public research university dedicated to providing a comprehensive education through bachelor's, master's, doctoral, and professional degree programs. Its mission focuses on engaging students in research and scholarship to empower them to address complex societal challenges effectively. The university offers a diverse array of academic disciplines, including science, history, mathematics, and arts, fostering a broad-based educational experience. As a non-profit institution, the University of Arizona emphasizes high-quality education and the development of leadership skills among its graduates.
University of Texas, El Paso
Grant in 2024
University of Texas at El Paso is highly regarded not only for its numerous degree programs, but also for the wealth of research opportunities and student life offerings. Since the academics at UT El Paso are so diverse and numerous, there is an array of degree offerings to be found. Six different schools feature majors in professional studies like Business, Education, Engineering, Occupational Therapy, Nursing and Law. More academic subjects include Linguistics, Jewish Studies, English and American Literature, Cultural Anthropology and Religious Studies. There are also performing and fine arts offerings in Film, Screenwriting, Creative Writing, Music, Musical Theatre, Fine Art, Dance and others. Numerous research facilities allow students and faculty to undertake research in such fields as Biomedical Studies, Education Reform and Engineering Systems. UT El Paso’s student life exists both on and off campus. On-campus activities include over 170 student clubs and organizations as well as student-run publications, recreational activities and entertainment. Off campus, students can find all of the cultural, entertainment and dining activities that exist in a city the size of El Paso. Admission to UT is fairly competitive, particularly at the graduate level. Undergraduate students are evaluated in terms of their academic performance and test scores, among other things. At the graduate level, a certain number of students may receive financial aid in the form of assistantships or fellowships. At the undergraduate level, eligible students get loans, grants and scholarships. Tuition is also much lower for state residents since UT is a state school.
University of North Carolina at Greensboro
Grant in 2024
The University of North Carolina at Greensboro, also known as UNCG and UNC Greensboro, is a public coeducational and research university in Greensboro in North Carolina in the United States of America, and it is a constituent institution of the system of the University of North Carolina. However, the University of North Carolina at Greensboro is a stand-alone university and awards its own degrees like all members of the system of the University of North Carolina . The Southern Association of Colleges and Schools Commission on Colleges accredits the University of North Carolina at Greensboro to award baccalaureate, masters, specialist, and doctoral degrees.
Benjamin Franklin Institute of Technology
Grant in 2024
If a technical career is what you seek, Benjamin Franklin Institute of Technology (BFIT) provides you with the education you need to pursue your professional goals. For over a century, BFIT has been one of Boston’s top career colleges. The institute has helped students reach their potential through technical education programs in the following types of fields: * Automotive Technology * Computer Technologies * Electronics Engineering Technology * Mechanical Engineering Technology * Medical Electronics Engineering Technology * Ophthalmic Assisting The Academic Success Center at BFIT ensures that students are given the resources and tools they need to excel in their academics and training. Some of the services offered through the center include: academic advising, special accommodations, tutoring, and more. College life at BFIT is filled with exciting experiences. From dorm life and council leadership to community service and intramural sports, the school encourages students to get involved in extracurricular activities. Applicants who are interested in admissions to the school must submit Accuplacer test results, an application, recommendation letters, and official transcripts for review. The school will waive its enrollment fee for any admissions applications submitted online. Merit and need-based financial aid exists in many forms at BFIT for those who qualify and are looking for tuition assistance.
West Virginia State University
Grant in 2024
West Virginia State University (WVSU), established in 1891 and located in Institute, West Virginia, offers a diverse range of undergraduate and graduate degree programs. Students can pursue degrees in fields such as Art, Biology, Criminal Justice, Music, Math, Political Science, Social Work, and ROTC, as well as a unique Regents Bachelor of Arts program tailored for non-traditional students. WVSU also provides graduate degrees in Biotechnology, Media Studies, and Law Enforcement, with options for online courses alongside traditional classroom settings. The university emphasizes student support through various services, including academic assistance, tutoring, and career services, featuring career fairs and workshops. On-campus housing and meal plans are available, and financial aid options include loans, grants, work-study, scholarships, and graduate fellowships for eligible students. WVSU is dedicated to delivering a personalized educational experience in a vibrant community.
Eastern Washington University
Grant in 2024
Eastern Washington University (EWU) boasts outstanding academic programs, with more than 100 fields of undergraduate study and over 50 graduate programs. This four-year public university offers students the opportunity to learn the skills they need for success. You will find excellent academic support and guidance at EWU, as well as top-notch academic programs in all disciplines from the arts to business, social sciences and engineering. Eastern has off-campus programs and online courses for the convenience of its students, all the while offering a centralized school spirit and pride for the community. Eastern Washington University is only 20 minutes from Spokane in the small college town of Cheney, and surrounded by the beautiful lakes and mountains that makes the inland Northwest so awe-inspiring and unique. Eastern encourages its students to explore their serene geographic backyard by partaking in its numerous recreational activities and student organizations. Although Eastern is one of the state’s fastest growing public universities, it is determined to maintain a 20:1 student-faculty ratio to nurture the academic growth of each student. EWU also aims to make learning convenient for its students by offering programs in Bellevue, Everett, Seattle, Kent, Tacoma, Vancouver, Yakima, and Shoreline. If you’re searching for an institution that goes beyond classroom learning to offer life experiences and encourage intellectual curiosity, Eastern Washington University should be on your list.
National Security Institute (NSI)
Grant in 2024
The National Security Institute (NSI) at George Mason University’s Antonin Scalia Law School is dedicated to finding real-world answers to national security law and policy questions. We strive to provide balance to the public discourse on the most difficult national security challenges facing the United States and its allies.
Vercel
Series E in 2024
Vercel Inc., established in 2015 and based in Walnut, California, specializes in developing a cloud platform for on-demand deployment of frontend applications. The company offers automated deployment solutions from pull requests via GitHub and Bitbucket, as well as merge requests through GitLab. Vercel's platform is designed to facilitate the development, previewing, and shipping of Jamstack sites, enabling efficient delivery of web pages through content delivery networks.
Delphia Therapeutics
Series A in 2024
Delphia Therapeutics, headquartered in Boston, USA, is a biotechnology company focused on developing innovative cancer treatments. It operates a laboratory where researchers study cancer-driving pathways to create targeted therapies. The company's approach involves selectively over-activating certain cancer-linked cell signaling pathways, making tumor cells unsustainable and enabling more effective cancer treatment for patients.
StrongDM
Series C in 2024
StrongDM, Inc. is a technology company based in Burlingame, California, founded in 2015. The company offers a platform designed to manage and audit access to various databases and servers for employees, vendors, and cloud-based tools. Its services enable organizations to efficiently create and remove users, manage permissions, and ensure proper data handling. StrongDM's platform simplifies the process of controlling access across multiple systems, enhancing security and compliance. In 2016, the company gained recognition as the Audience Favorite at the Strata+Hadoop World conference, highlighting its impact in the data management sector.
Cerevance
Series B in 2024
Cerevance LLC is a biotechnology company focused on developing innovative therapeutics for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Cambridge, United Kingdom, the company utilizes its NETSseq platform to profile specific brain cell types, including neurons and glial cells, using a repository of over 15,000 human brain tissue samples. This platform provides detailed expression and epigenetic data, allowing Cerevance to identify promising therapeutic targets for central nervous system diseases. Through its research, the company aims to advance new medicines that can potentially address the underlying mechanisms of these debilitating conditions.
Ripcord
Venture Round in 2024
Ripcord, Inc. is a robotic digitization company that specializes in automating the management of paper records. Founded in 2014 and headquartered in Los Angeles, California, Ripcord develops a platform that utilizes advanced technologies, including artificial intelligence, machine learning, and vision-guided robotics, to create digital twins of physical documents. Its flagship solution, Canopy, captures, enriches, and organizes critical content, allowing enterprises to enhance their business processes with improved speed, quality, and accuracy. Formerly known as Ripcord Digital, Inc., the company rebranded in June 2017 to reflect its focus on innovative digitization solutions.
Quadratic
Seed Round in 2024
Quadratic is a company based in Boulder, Colorado, that has developed a real-time spreadsheet designed to enhance data accessibility. Its platform allows users to pull data from various sources, including SaaS applications, databases, CSV files, and APIs. Users can manipulate and analyze this data using a range of data science tools such as Python, Pandas, SQL, JavaScript, and Excel formulas. By integrating data science and visualization capabilities, Quadratic aims to streamline the process of working with data and improve user experience in data analysis.
Alberta Machine Intelligence Institute
Grant in 2024
The Alberta Machine Intelligence Institute (Amii) is a non-profit organization based in Edmonton, Canada, founded in 2002. As one of Canada's three National AI Institutes, it plays a pivotal role in the Pan-Canadian AI Strategy. Amii is dedicated to advancing research in artificial intelligence and machine learning, facilitating the translation of scientific advancements into practical applications for industry. The institute focuses on enhancing AI capabilities through cutting-edge research, comprehensive educational programs, and tailored business advice, all aimed at fostering in-house AI development within organizations. Amii's commitment to excellence positions it as a leader in the field, contributing significantly to the growth of AI expertise in Canada.
Canadian Institute for Advanced Research
Grant in 2024
The Canadian Institute for Advanced Research enables Canadian researchers to work on international research teams that are custom built to transform their fields of study. CIFAR also fosters the development of the next generation of researchers in Canada and abroad. The Global Academy envelops all of CIFAR’s early-career activities, including our summer and winter schools of advanced study and our elite CIFAR Global Scholars.
Oula Health
Series B in 2024
Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.
Areteia Therapeutics
Series A in 2024
Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.
AST SpaceMobile
Post in 2024
AST SpaceMobile is a satellite designer and manufacturer headquartered in Midland, Texas, focused on creating the first global broadband cellular network in space. Founded in 2017, the company aims to provide direct connectivity to standard, unmodified mobile devices, addressing the connectivity gaps faced by billions of mobile subscribers worldwide. By leveraging its extensive intellectual property and patent portfolio, AST SpaceMobile is developing a service that offers cost-effective, high-speed cellular broadband to users in areas lacking terrestrial cellular coverage. The company's mission is to connect the unconnected by enabling reliable mobile communication for those who currently lack access to broadband services.
Oort
Venture Round in 2024
Oort is a decentralized data cloud platform focused on enhancing privacy and cost efficiency by harnessing global computing and storage resources. The company provides enterprise-grade cloud solutions tailored for generative AI and data-driven businesses. As a pioneer in intelligent decentralized data cloud technology, Oort is supported by U.S. patents and academic research. With a strong network of partnerships, Oort collaborates with over 40 projects and companies, including notable names such as DELL, Tencent Cloud, and Cardano, and has established connections with prestigious institutions like Harvard, MIT, and the University of Chicago. Headquartered in New York, Oort's core team comprises professionals from esteemed organizations such as Columbia University, Qualcomm, AT&T, and JP Morgan. The platform also employs blockchain technology to enable metaverse developers to access decentralized computing power, offering a scalable solution for web3-native products.
YMCA Dallas
Grant in 2023
YMCA of Metropolitan Dallas is a religious organization that focuses on youth development, healthy living, and social services. The organization was founded in 1885 and is based in Irving, Texas. YMCA of Metropolitan Dallas operates as a subsidiary of Ymca Of Greater Pittsburgh.
Censys
Series C in 2023
Censys, Inc. specializes in internet scanning and asset identification solutions, offering a platform that enables organizations to gain a real-time view of global networks and devices. Founded in 2017 and based in Ann Arbor, Michigan, Censys provides tools for attack surface management, allowing users to discover unknown assets, monitor remote workforces, and identify threat actors. Its internet intelligence platform is designed for threat hunting and exposure management, creating a comprehensive dataset that enhances visibility into vulnerabilities and internet-exposed infrastructure. This enables businesses to efficiently locate and manage the devices, networks, and infrastructure that are critical to their operations.
Hampton University
Grant in 2023
Hampton University in Hampton, Virginia, has been educating African-American students for more than 200 years. Today Hampton University is one of the most respected historically black universities in the nation. Academics range from technical certificates to liberal arts majors to master’s degree programs. Hampton University offers professional certifications in a number of fields and also awards bachelor’s degrees and graduate programs that include master’s degrees in Architecture, Counseling, Education, and Nursing. All of Hampton University’s programs have an established reputation for excellence. The school attracts students from more than 40 states and more than 35 countries and territories. Hampton University has also been recognized by the National Urban League, which named the school’s business program the best in the United States.
ROME Therapeutics
Series B in 2023
ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Established in 2019, the company utilizes the repeatome—a previously overlooked segment of genetic material—to create novel treatment options. By identifying multiple drug targets and advancing several discovery programs, ROME Therapeutics aims to tap into this unexplored area of biology. The organization has assembled a team of experts in oncology, immunology, virology, and machine learning to lead its research and development efforts, which are designed to provide healthcare professionals with effective new treatments for patients suffering from these conditions.
Nimbus Therapeutics
Private Equity Round in 2023
Nimbus Therapeutics, based in Cambridge, Massachusetts, is a biotechnology company focused on discovering and developing innovative medicines for serious diseases, including metabolic disorders, cancer, and immune-inflammatory conditions. The company utilizes advanced computational technologies to create selective and potent small-molecule therapeutics. Among its notable projects is the Nimbus Apollo program, which features the lead candidate NDI-010976, an allosteric inhibitor targeting Acetyl-CoA Carboxylase (ACC). This compound is being developed for the treatment of non-alcoholic steatohepatitis (NASH) and has potential applications in hepatocellular carcinoma (HCC) and other diseases. NDI-010976 received Fast Track designation from the U.S. Food and Drug Administration in 2016, highlighting its significance in the clinical development pipeline. Nimbus Therapeutics has formed strategic partnerships to enhance its research and development capabilities, reinforcing its commitment to advancing treatment options for complex health challenges.
Hugging Face
Series D in 2023
Hugging Face, established in 2016 and based in New York, specializes in open-source machine learning technologies. It operates a platform that facilitates collaboration on machine learning projects, including models, datasets, and applications. The company aims to democratize machine learning by providing tools and services that support and advance the field, while also offering paid computing and enterprise systems to accelerate development.
Voiceflow
Venture Round in 2023
Voiceflow Inc. is a Toronto-based company that provides a platform for creating and monetizing voice applications for smart speakers such as Alexa and Google Assistant. Founded in 2018, the platform enables users to design, prototype, and launch voice applications without the need for coding, utilizing a visual programming language and a drag-and-drop interface. Voiceflow aims to simplify the development process for content creators and businesses by allowing them to effectively build and distribute voice-driven applications. The company has gained traction among developers and enterprises looking to automate customer support and enhance user engagement through conversational interfaces.
Reefreshed
Seed Round in 2023
Reefreshed is a beauty platform that provides software marketplace for products & services to consumers and businesses with delivery for the beauty services marketplace ,consumers book beauty services by seamlessly integrating real-time booking and a virtual lineup system. Cashless and all payments made trough Reefreshed intelligently places you in a digital queue, allowing you to track your place in line and receive notifications when it's your turn. Also features category-specific SaaS platform for beauty providers and products . The company was founded in March 2020 and is headquartered in Toronto Canada.
Air Protein
Venture Round in 2023
Air Protein, based in Berkeley, California, is a startup focused on creating sustainable protein from carbon dioxide. Utilizing a proprietary probiotic process, the company transforms CO2 into protein-enriched food products such as meat-free burgers, protein-enriched pasta, cereals, and beverages. This innovative approach allows for the production of protein without the use of hormones, pesticides, or herbicides, while also significantly reducing land and water usage compared to traditional meat production. Air Protein aims to provide a viable alternative for meat lovers seeking sustainable food options.
University of Chicago
Grant in 2023
The University of Chicago is a private, coeducational research university known for its commitment to rigorous scholarship and interdisciplinary learning. It empowers scholars and students to explore complex questions and challenge conventional thinking across various fields, including sciences, medicine, economics, law, and business. The university offers more than 50 specialized undergraduate and graduate programs, including innovative interdisciplinary initiatives such as Big Problems, which addresses significant global challenges. In addition to its academic offerings, the university enhances community engagement by sponsoring numerous art and cultural events that are free to the public, held at venues like the Court Theatre, the Oriental Institute, and the Smart Museum. Its experiential programs, including "Chicago Careers In," provide students with valuable research opportunities and internships in diverse professional fields, contributing to both individual growth and the economic vitality of the surrounding city.
Antiva Biosciences
Series E in 2023
Antiva Biosciences is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral drugs to treat human papillomavirus (HPV) infections. Founded in 2012 and previously known as Hera Therapeutics, the company aims to prevent cancer by addressing precancerous lesions associated with HPV. Antiva's innovative approach involves localized therapeutics and small molecule antivirals designed to improve health outcomes for patients suffering from diseases linked to HPV and other viruses. The company's clinical programs target high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias, utilizing a medicinal chemistry platform that emphasizes the development and commercialization of direct-acting antivirals.
Clever Care Health Plan
Series C in 2023
Clever Care Health Plan, Inc. is a healthcare insurance provider that specializes in Medicare Advantage plans, integrating the principles of Eastern and Western medicine. Founded in 2018 and headquartered in Westminster, California, with an additional office in Arcadia, the company offers a range of culturally sensitive healthcare solutions. Its plans include access to services such as acupuncture, herbal remedies, tai chi, and cupping, aimed at enhancing both physical and mental well-being. Clever Care connects its members with diverse networks of hospitals and healthcare providers who are attuned to their cultural needs and language preferences. The company distributes its products through brokers and sales agents, ensuring that Medicare beneficiaries receive the support and services they require.
Chroma Medicine
Series B in 2023
Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.
Photomath
Acquisition in 2023
Photomath, Inc. is a math learning application developer based in San Mateo, California, founded in 2014. The app, which is the most widely used math education tool globally, serves over 300 million learners. It utilizes advanced AI technology to allow users to scan math problems with their device's camera, providing instant solutions and step-by-step explanations. This approach not only helps users solve equations ranging from basic arithmetic to calculus but also enhances their understanding of fundamental mathematical concepts. The company is supported by several investors, including Cherubic Ventures, Goodwater Capital, GSV Ventures, Menlo Ventures, and Learn Capital.
Reefreshed
Non Equity Assistance in 2023
Reefreshed is a beauty platform that provides software marketplace for products & services to consumers and businesses with delivery for the beauty services marketplace ,consumers book beauty services by seamlessly integrating real-time booking and a virtual lineup system. Cashless and all payments made trough Reefreshed intelligently places you in a digital queue, allowing you to track your place in line and receive notifications when it's your turn. Also features category-specific SaaS platform for beauty providers and products . The company was founded in March 2020 and is headquartered in Toronto Canada.
Superplastic
Series A in 2023
Superplastic, Inc. is a character-based product and entertainment company founded in 2017 and based in Burlington, Vermont. The company specializes in manufacturing and marketing limited edition art toys, apparel, games, and animation, featuring unique characters created in collaboration with renowned artists. Superplastic leverages the principles of effort and scarcity to enhance the value of its offerings, creating exclusive works of art for a select audience. The company also operates a platform that engages customers through various media, including animated videos and music, enabling interactions with its synthetic superstars in innovative ways. Products are primarily sold online, reflecting a modern approach to retail and entertainment.
Cerevance
Series B in 2023
Cerevance LLC is a biotechnology company focused on developing innovative therapeutics for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Cambridge, United Kingdom, the company utilizes its NETSseq platform to profile specific brain cell types, including neurons and glial cells, using a repository of over 15,000 human brain tissue samples. This platform provides detailed expression and epigenetic data, allowing Cerevance to identify promising therapeutic targets for central nervous system diseases. Through its research, the company aims to advance new medicines that can potentially address the underlying mechanisms of these debilitating conditions.
Chronosphere
Venture Round in 2023
Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.
Galileo
Series D in 2022
Galileo, Inc. is a technology company that specializes in providing healthcare solutions through a mobile application, enabling direct access to clinical care and expertise via smartphones. Founded in 2014 and headquartered in New York, the company facilitates communication between healthcare providers and patients using advanced telecommunications technologies. Galileo delivers high-touch, data-driven, multi-specialty care to a diverse patient population, offering services over the phone and in various settings. The company is recognized by regional and national health plans, employers, and major corporations for its effectiveness in enhancing population health. Galileo's mission is to address complex healthcare challenges and foster closer connections between patients and providers.
Cacheflow
Series A in 2022
Cacheflow is a zero-code software-as-a-service (SaaS) sales platform that automates the proposal-to-payment process, facilitating a seamless sales experience. Founded in 2021 and based in San Francisco, the company offers a solution that simplifies the SaaS sales flow by integrating various functions into a single platform. Sales teams can quickly generate dynamic quotes and streamline the buying process through features such as simple configuration, interactive checkout, and integrated payment options. Cacheflow's services include self-service checkout, flexible payment plans, and automated billing, all designed to enhance cash flow and improve client relationships, ultimately enabling SaaS businesses to sell more efficiently.
Dandelion Energy
Series B in 2022
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.
Contraline
Series A in 2022
Contraline, Inc. is a biotechnology company based in Charlottesville, Virginia, focused on developing male birth control solutions. The company is creating an innovative, long-lasting, non-hormonal, and reversible contraceptive known as Echo-V. This product consists of an ultrasound-visible polymer solution that is injected into the vas deferens, forming a polymer hydrogel device. This device acts as a semi-permeable membrane, effectively blocking sperm while allowing bodily fluids to pass through. Contraline also offers Vasintomy, a non-surgical procedure for the insertion of Echo-V, providing a cost-effective and user-friendly approach to male contraception. Founded in 2015, Contraline aims to transform male reproductive health through its groundbreaking technology.
Sound Life Sciences
Acquisition in 2022
Sound Life Sciences, Inc. is a Seattle-based company that specializes in developing clinically validated software for mobile phones and smart speakers. Founded in 2018, the company has created a sonar-based, contactless respiratory monitoring system designed to detect dangerous health conditions, including overdose and cardiac arrest. The application enables devices to monitor breathing changes in various scenarios, thereby facilitating the management of chronic diseases and enhancing emergency response capabilities. With a focus on improving health outcomes, Sound Life Sciences aims to provide tools that support physicians in both wellness and environmental sensing contexts.
Landis
Series B in 2022
Landis is an online real estate platform founded in 2018 and headquartered in New York, NY, that focuses on helping renters become homeowners. The company allows clients to choose their dream home, rent it, and purchase it within the first twelve months. In addition to facilitating this transition, Landis provides tools and incentives designed to assist clients in improving their credit scores and accumulating down payment savings. With a commitment to transparency and simplicity, Landis aims to create a seamless process for renters to transition to homeownership. The company also specializes in commercial real estate technology and residential offerings.
BrightBytes
Acquisition in 2022
BrightBytes Inc. operates a data analytics platform designed to enhance education by measuring and linking technology use to student learning outcomes. Founded in 2012 and based in San Francisco, California, the company provides a SaaS-based solution that equips educational leaders, including government agencies, school districts, and institutions, with the tools to analyze and improve learning outcomes. Its platform aggregates and cleanses complex data from various systems, offering insights through intuitive infographics, actionable recommendations, and targeted reports. By delivering data-driven insights and prioritizing technology programs and professional development, BrightBytes enables educational stakeholders to effectively manage technology deployment and assess its impact on student achievement. The team comprises data scientists, educational researchers, developers, and data visualization experts dedicated to fostering school-wide improvements through evidence-based frameworks and peer networks.
Rippl Care
Seed Round in 2022
Rippl Care is a mental health company based in Seattle, Washington, dedicated to supporting seniors experiencing dementia and other neurocognitive disorders. Founded in 2021, the company employs a value-based approach and innovative technology to deliver comprehensive care tailored to individual needs. By prioritizing the empowerment of its clinicians, Rippl Care adopts a novel care model that enables seniors to receive personalized support through various channels, including phone, online, and in-home visits. This commitment to enhancing the quality of care for those affected by neurocognitive conditions sets Rippl Care apart in the mental health landscape.
Flatfile
Series B in 2022
Flatfile Inc. is a company that specializes in data onboarding solutions, enabling developers to efficiently validate, map, and import CSV data from various web applications. Founded in 2018 and based in Denver, Colorado, Flatfile offers a platform that integrates seamlessly with software applications, allowing users to upload data through formats such as CSV, XLS, or TSV. Its key products include Portal, which provides an import button embedded via a JavaScript snippet, and Concierge, which creates secure collaborative workspaces for organizations to manage complex data ingestion challenges. The platform is designed to enhance developer productivity, reduce costs, and improve data quality by learning to identify and clean incoming data over time. Numerous companies, including AstraZeneca and Square, utilize Flatfile’s API-first platform to streamline their data import processes.
BreezoMeter
Acquisition in 2022
BreezoMeter Ltd. is a company specializing in real-time air quality monitoring and health recommendations for consumers and businesses, operating primarily in the United States and Israel. Founded in 2014 and headquartered in Haifa, Israel, with an additional office in the U.S., BreezoMeter provides street-level air quality data and tailored health solutions for various demographics, including children and athletes. Its suite of APIs offers information on air pollution, pollen, and active fires, making it a preferred choice for companies like Siemens and Tata Motors. The company employs a unique multi-data layer approach that integrates data from governmental sensors, satellites, and weather patterns to achieve high accuracy in air quality reporting. With sophisticated modeling and artificial intelligence, BreezoMeter calculates air quality metrics at a resolution of 0.003 miles (5 meters/16 feet) on an hourly basis across more than 90 countries.
Verily
Corporate Round in 2022
Verily is an Alphabet health technology company focused on research, care, and health financing to deliver on the promise of precision health and help people live healthier lives. We are uniquely positioned at the intersection of technology, data science, and healthcare to create tools to accelerate evidence generation, products to enable more personalized care, and approaches to make costs more predictable. For more information about Verily please visit verily.com. The company was founded in 2015 and is based in San Francisco, California, United States.
Isovalent
Series B in 2022
Isovalent, Inc. specializes in developing software solutions for enterprises to connect, monitor, and secure workloads in cloud-native environments. The company's flagship product, Cilium, leverages eBPF to enhance networking, security, and observability for Kubernetes deployments across both cloud and on-premises infrastructures. Isovalent offers Cilium Enterprise, which focuses on security automation, compliance, and integration with legacy systems, along with open-source tools that facilitate network connectivity, threat detection, and security compliance monitoring. Founded by the creators of Cilium and eBPF, Isovalent serves a diverse clientele, including major organizations like Adobe, AWS, and Google. The company was established in 2016 and has its headquarters in Cupertino, California, with an additional office in Zurich, Switzerland.
Zeet
Seed Round in 2022
Zeet is a developer-focused application platform established in 2020 and based in San Francisco, California. The company simplifies the code deployment process by enabling users to deploy applications to various cloud providers, including AWS and GCP. Zeet's all-in-one DevOps software offers a cloud-native setup that allows clients to manage self-hosted open-source projects seamlessly. This functionality empowers developers to concentrate on product delivery rather than getting bogged down in complex deployment configurations.
Omni
Series A in 2022
Omni is a multifaceted company based in San Francisco, California, that specializes in business intelligence, cybersecurity, and cloud engineering services. Its primary offering is a unique business intelligence platform that merges the reliability of a shared data model with the flexibility of SQL, allowing users to easily access, explore, and share curated data metrics. This platform is designed to streamline the data analytics process, enabling clients to focus on deriving meaningful insights without the complications often associated with data management. Additionally, Omni operates a rentals platform that connects local businesses with community members, providing access to a variety of rental items such as bikes, surfboards, and camping equipment. This initiative enhances community engagement by making diverse products readily available for short-term use.
Fractyl Health
Series F in 2022
Fractyl Health, based in Lexington, Massachusetts, specializes in developing innovative medical device solutions for metabolic diseases, particularly type 2 diabetes and obesity. The company’s primary offering, Revita DMR, is a minimally invasive therapy that utilizes hydrothermal ablation to rejuvenate the duodenal lining, which can become compromised due to high-fat and high-sugar diets. By focusing on durable disease-modifying therapies rather than just symptomatic management, Fractyl Health aims to address the underlying causes of metabolic diseases, improving patient outcomes and reducing healthcare burdens. Founded in 2010 and originally named MedCatalyst, Inc., the company envisions a future where less invasive, device-based therapies provide effective solutions for large populations affected by metabolic disorders.
Acalvio
Series D in 2022
Acalvio is a cybersecurity company based in Silicon Valley, specializing in deception technology to protect against advanced security threats. Their flagship product, the ShadowPlex Cyber Deception Platform, leverages 25 issued patents in autonomous deception and advanced AI to offer solutions such as Identity Threat Detection and Response (ITDR), Advanced Threat Detection, OT Security, Zero Trust, Active Directory Protection, and Ransomware Protection. Acalvio's technology is designed to reduce the time attackers spend undetected within a network by enabling early threat detection and enhancing the efficiency of security operations centers through sophisticated investigation and active threat-hunting capabilities. The company serves Fortune 500 enterprises and government agencies, with deployment options including on-premises, cloud, and managed service providers.
TAE
Series G in 2022
TAE Technologies, Inc. is a company focused on developing clean fusion energy through advanced particle accelerator and plasma physics. Founded in 1998 and headquartered in Foothill Ranch, California, with an additional office in Rancho Santa Margarita, TAE Technologies aims to create a new source of energy derived from natural processes that generates no harmful byproducts. With over two decades of research, the company is dedicated to commercializing safe and cost-effective fusion power solutions. TAE Technologies also contributes to advancements in power management, electric mobility, and life sciences, addressing the global energy demand while promoting sustainable and carbon-free energy alternatives.
Merlin Labs
Series B in 2022
Merlin Labs is an innovative company focused on creating autonomous flight technology for advanced air travel, primarily utilizing fixed-wing aircraft. Founded in 2018 and headquartered in Boston, Massachusetts, the company develops a sophisticated aircraft autonomy system that employs artificial intelligence and machine learning, akin to the technology used in driverless cars. This system aims to facilitate the pilotless transportation of goods and eventually people, establishing a new infrastructure for aerial mobility.
Xilis
Series A in 2022
Xilis, Inc. is a biotechnology company based in Chapel Hill, North Carolina, founded in 2019. It specializes in developing advanced organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. The company's flagship platform, XilisµO, facilitates rapid diagnostics and personalized drug screening while providing scalable, patient-derived models for high-throughput drug discovery. This technology supports physicians and pharmaceutical companies in creating tailored treatments by enabling effective drug screening, ultimately contributing to more precise and cost-efficient cancer therapies.
Areteia Therapeutics
Series A in 2022
Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.
FYTO
Series A in 2022
FYTO, Inc. is a company based in Cambridge, Massachusetts, that focuses on developing plant-based feed production systems aimed at enhancing the sustainability of agriculture. Founded in 2019, FYTO specializes in creating nutrient-dense crops that require minimal resources, alongside cultivation and harvesting systems designed to ensure quality and consistency. The company's offerings include a variety of agricultural products such as animal feed, plant-based proteins, nutritional supplements, and bio-fertilizers. By adopting climate-friendly practices and methodologies, FYTO aims to support farmers globally in achieving improved economic and environmental outcomes in their agricultural operations.
Medallion
Series C in 2022
Medallion is a company that offers a network management platform tailored for the healthcare industry, focusing on simplifying the complex processes of licensing, credentialing, and payer enrollment. Founded in 2020 by Derek Lo and based in San Francisco, California, Medallion's all-in-one platform addresses the logistical challenges that healthcare providers and telemedicine companies face, enabling them to minimize time spent on administrative tasks. Key features of the platform include facilities for new licensing and renewals, primary source verification, continuing medical education tracking, and document management. By streamlining these processes, Medallion allows healthcare professionals to concentrate more on patient care rather than paperwork.
Ahana
Series A in 2022
Ahana, founded in 2020 and based in San Mateo, California, specializes in developing ad hoc analytics solutions built on PrestoDB. The company aims to simplify interactive analytics for organizations of various sizes, providing a platform that facilitates efficient data analysis. Recognizing the widespread adoption of Presto in major internet companies, Ahana focuses on bringing these capabilities to a broader audience while actively promoting and supporting the Presto community. Through its offerings, Ahana seeks to enhance the accessibility and usability of ad hoc analytics across diverse sectors.
Sesame
Series B in 2022
Sesame, Inc., also known as SesameCare, is a New York-based company founded in 2018 that specializes in providing a platform for booking medical appointments and consultations. The company distinguishes itself by offering affordable healthcare options, enabling Americans to access quality medical services at significantly reduced prices compared to traditional providers. By utilizing an AI-enabled marketplace, Sesame eliminates the need for insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. Additionally, Sesame serves as the official telehealth partner of Costco, further enhancing its reach and service offerings in the healthcare sector.
Nava
Series B in 2022
Nava is a health insurance brokerage based in New York, New York, dedicated to providing high-quality, affordable healthcare solutions to employers and their employees. The company offers a range of services that include healthcare tools, year-round employee advocacy, and continuous evaluation of healthcare plans. By leveraging these resources, Nava empowers clients to deliver essential benefits while simultaneously reducing overall plan costs. Its innovative approach aims to transform the employee benefits landscape through enhanced access and advocacy in healthcare.
Strella Biotechnology
Series A in 2022
Strella Biotechnology, Inc. is a Philadelphia-based company that designs and manufactures sensor-based devices aimed at maximizing the freshness of produce throughout the supply chain. Founded in 2018 by Jacob Jordan and Katherine Sizov, the company specializes in ethylene detection technology, which assesses the ripeness of fruit by measuring the ethylene gas emitted during ripening. This innovation helps to optimize the produce supply chain by providing critical data that reduces spoilage and enhances the management of fresh produce. Strella Biotechnology leverages its patented technology to support efficiency and maintain quality in food distribution.
FarmWise
Series B in 2022
FarmWise, established in 2016 and headquartered in San Francisco, specializes in developing and manufacturing robotic machinery for agriculture. The company's primary product is a mechanical weeder, designed to efficiently remove weeds and thin crops, thereby enhancing agricultural productivity. FarmWise also provides comprehensive training and support to ensure the effective use of its technology.
Gametime
Venture Round in 2022
Gametime is a mobile platform that specializes in selling last-minute tickets for a variety of live events, including sports, concerts, and theater, across the United States and Canada. The service simplifies the ticket purchasing process by curating a selection of the best available options from over 10,000 seats, allowing clients to choose from 50 top values. Each ticket option is accompanied by a high-resolution panoramic photo, providing users with a preview of the view from their chosen section. The platform features interactive seat maps that allow for easy comparison of prices and locations, enhancing the customer experience. Tickets are conveniently delivered directly to the user's phone, facilitating instant access to entertainment.
Mirvie
Series B in 2022
Mirvie is a biotech company focused on developing non-invasive tests aimed at improving maternal-fetal health. Founded in 2018 and based in South San Francisco, California, Mirvie offers a medical diagnostic platform that provides actionable insights for mothers and families throughout their pregnancy journey. The company's innovative predictive tests help medical practitioners identify at-risk pregnancies, allowing for timely interventions and enhanced management of pregnancy-related concerns. By prioritizing safety and health, Mirvie seeks to empower families with the information necessary for better pregnancy outcomes.
Invetx
Series B in 2022
Invetx, Inc. is a biotechnology company focused on developing protein-based therapeutics for animal health care and veterinary medicine. Based in Boston, Massachusetts, Invetx's team comprises veterinary scientists and clinicians dedicated to discovering and creating biotherapeutics for both pets and farm animals. The company aims to enhance health outcomes in the animal health industry by leveraging biopharma technologies, supported by a network of experts in animal and human health. Through its innovative platform, Invetx is committed to advancing a portfolio of therapies and technologies designed to improve animal care and well-being.
Aspen Neuroscience
Series B in 2022
Aspen Neuroscience, Inc. is a biotechnology company focused on developing induced pluripotent stem cells (iPSCs) to create patient-specific therapies for neurological conditions, particularly Parkinson's disease. Founded in 2018 and based in San Diego, California, the company is advancing its pipeline of products, which includes ANPD001, an autologous neuron replacement therapy for sporadic Parkinson's disease, and ANPD002, a gene-edited autologous neuron replacement therapy targeting familial forms of the disease. Aspen Neuroscience employs innovative genomic approaches in conjunction with stem cell biology to address diseases with significant unmet medical needs, aiming to provide restorative cell therapies that can modify the progression of Parkinson's disease and potentially extend to other affected organs.
Doppler
Series A in 2022
Doppler Technologies, Inc., established in 2018, specializes in developing and operating secret management software solutions. The company's flagship product, Doppler, is a secure software solution designed to store and manage software secrets such as API keys, credentials, environment variables, and database URLs. Doppler's platform is language, stack, and infrastructure agnostic, enhancing developer productivity while bolstering overall security. It securely stores and manages these secrets, enabling developers and security teams to maintain synchronization and security across various devices, environments, and team members.
Omni
Seed Round in 2022
Omni is a multifaceted company based in San Francisco, California, that specializes in business intelligence, cybersecurity, and cloud engineering services. Its primary offering is a unique business intelligence platform that merges the reliability of a shared data model with the flexibility of SQL, allowing users to easily access, explore, and share curated data metrics. This platform is designed to streamline the data analytics process, enabling clients to focus on deriving meaningful insights without the complications often associated with data management. Additionally, Omni operates a rentals platform that connects local businesses with community members, providing access to a variety of rental items such as bikes, surfboards, and camping equipment. This initiative enhances community engagement by making diverse products readily available for short-term use.
Viz
Series D in 2022
Viz.ai, Inc. specializes in healthcare imaging software designed to enhance stroke care through the use of artificial intelligence. The company's flagship technology synchronizes treatment by reducing delays in patient care, enabling rapid identification of large vessel occlusion (LVO) strokes using advanced deep learning algorithms. Key offerings include Viz LVO, which alerts on-call stroke teams based on CT angiogram images, and Viz CTP, which analyzes CT perfusion images and generates critical parametric data. Additionally, Viz HUB facilitates communication among clinical teams to coordinate care efficiently, while Viz VIEW allows healthcare professionals to view imaging data on mobile devices. Founded in 2016 and headquartered in San Francisco, the company aims to transform healthcare delivery by improving the speed and accessibility of treatment for stroke patients.
Obsidian Security
Series C in 2022
Obsidian Security, Inc. develops cloud infrastructure and data center security solutions, focusing on cybersecurity and artificial intelligence to address cyber threats in hybrid-cloud environments. The company provides a platform that enables threat detection, breach remediation, and security hardening specifically for business-critical software as a service (SaaS) applications. By delivering cloud detection and response capabilities, Obsidian Security aims to enhance the security posture of enterprises. Founded in 2017 and headquartered in Newport Beach, California, the company is dedicated to creating a comprehensive understanding of interconnected applications to ensure their safety and security.
Brightline
Series C in 2022
Brightline, Inc. is a provider of pediatric behavioral health care services, established in 2019 and headquartered in Palo Alto, California. The company offers a range of services including behavior therapy, psychiatry and medication support, speech-language therapy, and occupational therapy. Brightline operates as a technology-enabled behavioral health home, utilizing innovative technology and virtual services to deliver integrated care. Its collaborative care team focuses on supporting children throughout their developmental stages and addressing the needs of their families. Brightline was previously known as Emilio Health, Inc. and rebranded in May 2020.
Elly
Venture Round in 2022
Elly Health Inc. develops innovative audio companion software designed to support patients, healthcare providers, and organizations. The company's flagship product, Elly, serves as an empathetic audio companion for individuals managing chronic diseases. By leveraging technology, Elly motivates and offers guidance from experts and contributors, enhancing the support system for those living with chronic conditions. Founded in 2019 and based in Los Angeles, California, Elly Health aims to improve patient experience and engagement in healthcare.
Digits
Series C in 2022
Digits Financial, Inc. is a fintech company founded in 2018 and based in San Francisco, California. The company specializes in developing software that offers a real-time view of a business's finances. Its platform streamlines the creation of financial reports and transaction records, significantly reducing manual workload. By visualizing and managing financial data, Digits enhances interactions between businesses and their accountants, investors, and advisors. This innovative approach positions Digits as a key player in providing modern financial solutions for businesses.
Celsius Therapeutics
Series B in 2022
Celsius Therapeutics is a biotechnology company focused on developing precision medicines for patients with cancer and autoimmune diseases. Founded in 2018 and based in Cambridge, Massachusetts, the company employs a team of scientists, technologists, computational biologists, clinicians, and drug hunters. Utilizing single-cell genomic analysis and machine learning techniques, Celsius Therapeutics aims to discover and create innovative therapies that can lead to significant improvements in patient outcomes. The company's research efforts are centered on identifying new drug candidates that address unmet medical needs in the therapeutic landscape.
LifeMine Therapeutics
Series C in 2022
LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.